Andorra vs Central America: Proportion of the target population who received a 3rd dose of
Andorra
96.0%
in 2024
Central America
80.0%
in 2024
Andorra rank
16th
Central America rank
13th
Proportion of the target population who received a 3rd dose of over time
- Andorra
- Central America
How they compare
Andorra currently reports 96.0% against 80.0% in Central America, a difference of 16.0%.
That makes Andorra's figure about 1.2 times Central America's.
The two have swapped places 2 times across 11 shared years of data; in 2014 it was Andorra ahead.
Andorra ranks 16th and Central America ranks 13th of 157 countries.
Andorra has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Andorra | Central America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 94.2% | 90.5% | 3.7% | Andorra |
| 2020s | 95.2% | 81.4% | 13.8% | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Andorra or Central America?
- Andorra, at 96.0% against 80.0% in Central America as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Andorra and Central America?
- 16.0%, with Andorra ahead.
- How many years of comparable data are there for Andorra and Central America?
- 11 years are reported by both, from 2014 to 2024.
- How do Andorra and Central America rank globally for proportion of the target population who received a 3rd dose of?
- Andorra ranks 16th and Central America ranks 13th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.